Author

Raf Bisschops 1

1 Katholieke Universiteit Leuven Universitair Ziekenhuis Dept. of Gastroenterology

How to manage dysplasia: Snare, knife or surgery? The endoscopical vs the surgical view

André D'Hoore, Raf Bisschops

How to report a normal Barrett’s esophagus?

Raf Bisschops

IMPACT OF ABLATION VS. SURVEILLANCE ON QUALITY OF LIFE AND ILLNESS PERCEPTION IN PATIENTS WITH BARRETT’S OESOPHAGUS CONTAINING LOW-GRADE DYSPLASIA: A MULTI-CENTER RANDOMISED CONTROLLED TRIAL.

Wilda Rosmolen, Nadine Phoa, Pythia Nieuwkerk, Bas L.A.M. Weusten, Raf Bisschops, Erik Jan Schoon, Mirjam Sprangers, Jacques J. Bergman

IMPACT ON AEROSOL GENERATION OF A MOUTHPIECE DESIGNED TO REDUCE DROPLET SPREAD OF COVID-19 DURING UPPER GASTROINTESTINAL ENDOSCOPY, A SINGLE CENTER RANDOMIZED CONTROLLED TRIAL

I-Hsuan Huang, Pieter Sinonquel, Herman Devriese, Chelsea Camps, Lieselot Holvoet, Bram Verstockt, Jan Tack, Hilde Willekens, Raf Bisschops

Improving neoplasia detection during endoscopy

Raf Bisschops

In patients with an overall cleansing success the 1L polyethylene glycol NER1006 achieves more high-quality cleansed segments per patient than three standard bowel preparations

Raf Bisschops, Jonathan Manning, Juha Halonen, Marco Antonio Álvarez-González

IN PATIENTS WITH AN OVERALL CLEANSING SUCCESS THE 1L POLYETHYLENE GLYCOL NER1006 ACHIEVES MORE HIGH-QUALITY CLEANSED SEGMENTS PER PATIENT THAN THREE STANDARD BOWEL PREPARATIONS

Raf Bisschops

Introduction on the QIC project: Where are we now after publication of performance measures

Raf Bisschops

Key quality measures in upper GI endoscopy. Report of the upper GI working group

Raf Bisschops

LANREOTIDE AUTOGEL 120 MG FOR CHRONIC REFRACTORY DIARRHEA : A MULTICENTER PROSPECTIVE TRIAL.

Raf Bisschops, Vincent De Ruyter, Gauthier Demolin, Didier Baert, Tom Moreels, Piet Pattyn, Hans Verhelst, Luc Lepoutre, Joris Arts, Philip Caenepeel, Patrick Ooghe, Pascal Maisonobe, Jan Tack

Item 41 - 50 / 110
1
...
2 3 4
5
6 7 8
...
11